This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
MONDAY, May 27, 2024 -- If you're one of the millions of Americans walking around with a new knee or hip, your odds for an infection in that joint rise if you ever have to undergo cancer chemotherapy, researchers report.“Given the number of people o.
MONDAY, May 27, 2024 -- "Ugh, I'm so busy these days I can barely think straight. It's so crazy."No doubt some friend or coworker (maybe even yourself) has moaned about how stressed and overworked they are. Sometimes its fully justified, but in.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
MONDAY, May 27, 2024 -- Does advising your teen sometimes feel like talking to the proverbial brick wall?Don't fret: New research shows that even when your preteen or teen gives your advice a flat "no way," your counsel is probably having an.
ACULAR LS (ketorolac tromethamine) Abbvie Patent: 9,216,167 Expiration: May 28, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
ACULAR LS (ketorolac tromethamine) Abbvie Patent: 9,216,167 Expiration: May 28, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.
MONDAY, May 27, 2024 -- Sipped from porcelain cups amid the music of Mozart and periwigs of the 1700s, tea was introduced to England and began its quiet work saving thousands of lives, new research confirms.It wasn't the leaves that kept tea.
Hyman, Phelps & McNamara, P.C. (HPM) proudly announces the return of Jennifer Newberger as a Director, further boosting its already robust medical device practice. Jennifer’s combination of experiences as in-house counsel for both large and start-up companies as well as outside counsel provides clients invaluable expertise and problem-solving skills.
Rapid advancements in biomedical research have underscored the need for new drug discovery tools that offer a transformative pathway to expedite the identification and development of novel therapeutic interventions. Mesenchymal Stem Cells (MSCs; also known as Mesenchymal Stromal Cells) provide researchers with a crucial tool they need to revolutionize therapeutic development.
Caris Life Sciences® (Caris) has been at the forefront of precision medicine. How does the company see antibody-drug conjugates (ADCs) fitting into this approach? Antibody-drug conjugates have seen explosive growth in the last few years which has materialised with numerous clinical trials demonstrating meaningful improvements in survival. However, biopharma pipelines have been focused on optimising linkers and payloads around a relatively small number of cell-surface targets.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Seamless integration between various systems and applications is crucial for efficient data sharing and enhanced functionality. Appian, a leading low-code automation platform, recognizes this need and provides a powerful toolset for creating Web APIs. Web APIs: Bridging the Gap Web APIs, or Application Programming Interfaces, serve as a bridge between different software applications, enabling them to communicate and share data seamlessly.
Following our recent Teach me in Ten Talk, we’re looking at how organoid technology is changing the landscape of preclinical drug screening. These FAQs outline the advantages, scalability, and translatability of using organoids for drug screening, offering insights that bridge the gap between laboratory research and clinical application.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content